MwanzoEDIT • NASDAQ
add
Editas Medicine Inc
Bei iliyotangulia
$ 1.56
Bei za siku
$ 1.54 - $ 1.69
Bei za mwaka
$ 0.91 - $ 6.69
Thamani ya kampuni katika soko
130.59M USD
Wastani wa hisa zilizouzwa
2.10M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 30.60M | -49.03% |
Matumizi ya uendeshaji wa biashara | 16.35M | 13.14% |
Mapato halisi | -45.40M | -140.52% |
Kiwango cha faida halisi | -148.33 | -371.94% |
Mapato kwa kila hisa | -0.55 | -139.13% |
EBITDA | -32.98M | -46.60% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 269.91M | -16.46% |
Jumla ya mali | 341.59M | -31.57% |
Jumla ya dhima | 207.32M | 38.16% |
Jumla ya hisa | 134.27M | — |
hisa zilizosalia | 82.98M | — |
Uwiano wa bei na thamani | 0.96 | — |
Faida inayotokana na mali | -25.67% | — |
Faida inayotokana mtaji | -44.81% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -45.40M | -140.52% |
Pesa kutokana na shughuli | -50.76M | -128.25% |
Pesa kutokana na uwekezaji | 30.96M | -50.74% |
Pesa kutokana na ufadhili | 55.51M | 10,700.19% |
Mabadiliko halisi ya pesa taslimu | 35.71M | -13.15% |
Mtiririko huru wa pesa | -23.35M | -45.40% |
Kuhusu
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Ilianzishwa
Nov 2013
Tovuti
Wafanyakazi
246
